2
RESEARCH METHODOLOGY
38
5
MARKET OVERVIEW
AI-driven precision medicine revolutionizes healthcare through personalized treatments and predictive analytics advancements.
61
5.3.1.1
INCREASE IN INVESTMENTS IN R&D AND RISE IN DEMAND FOR PERSONALIZED MEDICATION
5.3.1.2
ADVANCEMENTS IN GENOMIC RESEARCH AND DATA AVAILABILITY
5.3.1.3
GROWTH IN CROSS-INDUSTRY COLLABORATIONS AND PARTNERSHIPS
5.3.1.4
ROLE OF REGULATORY LANDSCAPE IN DRIVING AI ADOPTION IN HEALTHCARE
5.3.2.1
INCREASE IN DATA BREACH CONCERNS
5.3.2.2
HIGH COST OF IMPLEMENTATION OF PRECISION MEDICINE SOLUTIONS
5.3.2.3
ACCURACY CHALLENGES IN AI ADOPTION FOR HEALTHCARE
5.3.3.1
ROLE OF PREDICTIVE ANALYTICS IN ADVANCING AI FOR HEALTHCARE
5.3.3.2
LEVERAGING RESEARCH PIPELINES AND NEW DRUG DEVELOPMENT FOR AI IN HEALTHCARE
5.3.4.1
IMPACT OF FAIRNESS AND BIAS ON AI IN HEALTHCARE
5.3.4.2
INTEROPERABILITY CHALLENGES DUE TO COMPLEXITY OF AI SOLUTIONS
5.4
TRENDS/DISRUPTIONS IMPACTING CUSTOMER BUSINESSES
5.5.1
AI'S GROWING ROLE IN PATIENT-SPECIFIC DATA INTEGRATION AND ANALYSIS
5.5.2
ADVANCEMENTS IN AI-POWERED PREDICTIVE ANALYTICS FOR TREATMENT OPTIMIZATION
5.8.1.1
PREDICTIVE ANALYTICS
5.8.1.4
CELL AND GENE THERAPIES
5.8.1.5
AI-DRIVEN SINGLE-CELL ANALYSIS
5.8.2
COMPLEMENTARY TECHNOLOGY
5.8.2.1
HIGH-PERFORMANCE COMPUTING (HPC)
5.8.2.2
NEXT-GENERATION SEQUENCING
5.8.2.3
REAL-WORLD EVIDENCE/REAL-WORLD DATA
5.8.2.5
DIGITAL HEALTH PLATFORMS
5.8.3
ADJACENT TECHNOLOGIES
5.8.3.2
BLOCKCHAIN TECHNOLOGY
5.8.3.3
INTERNET OF THINGS (IOT) AND WEARABLES
5.8.3.4
ROBOTICS AND AUTOMATION
5.8.3.5
3D PRINTING FOR PERSONALIZED IMPLANTS AND DEVICES
5.9.1
REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
5.9.2
REGULATORY SCENARIO
5.10.1
INDICATIVE PRICING FOR KEY PLAYERS
5.10.2
INDICATIVE PRICE OF KEY COMPONENTS, BY REGION
5.11
PORTER’S FIVE FORCES ANALYSIS
5.11.1
THREAT OF NEW ENTRANTS
5.11.2
THREAT OF SUBSTITUTES
5.11.3
BARGAINING POWER OF SUPPLIERS
5.11.4
BARGAINING POWER OF BUYERS
5.11.5
INTENSITY OF COMPETITIVE RIVALRY
5.12.1
PATENT PUBLICATION TRENDS
5.12.2
JURISDICTION ANALYSIS: TOP APPLICANT COUNTRIES FOR AI IN PRECISION MEDICINE
5.12.3
KEY PATENTS IN AI IN PRECISION MEDICINE MARKET
5.13
KEY STAKEHOLDERS AND BUYING CRITERIA
5.13.1
KEY STAKEHOLDERS IN BUYING PROCESS
5.13.2
KEY BUYING CRITERIA
5.14.2
END-USER EXPECTATIONS
5.15
KEY CONFERENCES & EVENTS
5.16.1
SANOFI LEVERAGED AI-DRIVEN PRECISION MEDICINE TO IDENTIFY PATIENT SUBTYPES AND NOVEL TARGETS IN INFLAMMATORY BOWEL DISEASE
5.16.2
IBM’S AI-DRIVEN SOLUTION IMPROVED CLINICAL TRIAL ENROLLMENT AT MAYO CLINIC BY ENHANCING PATIENT MATCHING
5.16.3
ENHANCING PATIENT IDENTIFICATION FOR RARE ONCOLOGY BIOMARKERS THROUGH GENOMIC TESTING AND STRATEGIC COLLABORATION
5.17
INVESTMENT AND FUNDING SCENARIO
5.19
IMPACT OF AI/GEN AI IN PRECISION MEDICINE MARKET
5.19.2
CASE STUDIES OF AI/GENERATIVE AI IMPLEMENTATION
5.19.2.1
ENHANCING PATIENT OUTCOMES WITH AI-DRIVEN PREDICTIVE ANALYTICS AT JOHNS HOPKINS HOSPITAL
5.19.3
IMPACT OF AI/GEN AI ON INTERCONNECTED AND ADJACENT ECOSYSTEMS
5.19.3.1
AI IN DRUG DISCOVERY MARKET
5.19.3.3
ARTIFICIAL INTELLIGENCE MARKET
5.19.3.4
PHARMACOGENOMICS MARKET
5.19.4
USER READINESS AND IMPACT ASSESSMENT
5.19.4.1.1
HEALTHCARE PROVIDERS
5.19.4.1.2
PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES
6
ARTIFICIAL INTELLIGENCE IN PRECISION MEDICINE MARKET, BY APPLICATION
Market Size & Growth Rate Forecast Analysis to 2030 in USD Million | 18 Data Tables
115
6.2
DRUG DISCOVERY & DEVELOPMENT
6.2.2
UNDERSTANDING DISEASES
6.2.2.1
RISE IN DATA MINING TO LINK TARGETS TO DISEASES
6.2.3.1
USE OF GRAPHS FOR TARGETED APPROACH TO REDUCE TIMELINES AND COSTS
6.2.4
DE NOVO DRUG DESIGN
6.2.4.1
AVAILABILITY OF LARGE-SCALE BIOMEDICAL DATASETS AND URGENT DEMAND FOR NOVEL TREATMENTS FOR COMPLEX DISEASES
6.2.5.1
NEED TO PROCESS EXTENSIVE DATA ON MOLECULAR PROPERTIES, TARGET INTERACTIONS, AND CLINICAL OUTCOMES
6.2.6.1
BUILDING GENERALIZABLE MODEL FOR TOXICITY AND OFF-TARGET EFFECT PREDICTION
6.2.7
CLINICAL DEVELOPMENT
6.2.7.1
DESIGNING AND CONDUCTING CLINICAL TRIALS FOR PERSONALIZED DOSING, TARGETED THERAPIES
6.3
DIAGNOSTICS & SCREENING
6.3.1
RISK ASSESSMENT & PATIENT STRATIFICATION
6.3.1.1
LEVERAGING AI TO PERSONALIZE TREATMENT PLAN
6.3.2.1
LEVERAGING MACHINE LEARNING TO PERUSE AND RESOLVE COMPLEX PATIENT DATA
6.3.3.1
IDENTIFYING BIOMARKERS FOR PRECISE TREATMENT
6.3.4
DISEASE PROGRESSION, STAGING, AND PROGNOSIS
6.3.4.1
USING AI TO TRACK DISEASE CONDITIONS
6.4.1
THERAPY SELECTION & PLANNING
6.4.1.1
LEVERAGING GENERATIVE MODELS TO PREDICT AND DESIGN SUITABLE TREATMENT
6.4.2.1
NEED TO EFFECTIVELY TRACK SAFETY AND EFFICACY OF TREATMENT
6.4.3
POST-TREATMENT SURVEILLANCE & FOLLOW-UP
6.4.3.1
AI ALGORITHMS TO IDENTIFY SUBTLE PATTERNS IN DATA, ALLOWING FOR EARLY DETECTION OF POTENTIAL ISSUES
7
ARTIFICIAL INTELLIGENCE IN PRECISION MEDICINE MARKET, BY THERAPEUTIC AREA
Market Size & Growth Rate Forecast Analysis to 2030 in USD Million | 9 Data Tables
133
7.2.1
HIGH PREVALENCE OF CANCER AND SHORTAGE OF EFFECTIVE CANCER DRUGS
7.3.1
COMBATING CHALLENGING THERAPEUTICS DUE TO COMPLEX AND HETEROGENEOUS NATURE OF RARE DISEASES
7.4.1
NEED FOR INNOVATION IN INFECTIOUS DISEASE TREATMENT, ESPECIALLY AFTER IMPACT OF COVID-19
7.5.1
SHORTAGE AND COMPLEXITY OF NEURODEGENERATIVE DISEASES
7.6.1
WIDE RANGE AND INCIDENCE OF CARDIOVASCULAR DISEASES
7.7.1
AI-DRIVEN ALGORITHMS TO ANALYZE BLOOD SAMPLES, IMAGING DATA, AND GENOMIC PROFILES TO DETECT ABNORMALITIES
7.8
OTHER THERAPEUTIC AREAS
8
ARTIFICIAL INTELLIGENCE IN PRECISION MEDICINE MARKET, BY COMPONENT
Market Size & Growth Rate Forecast Analysis to 2030 in USD Million | 3 Data Tables
145
8.2.1
SCALABILITY AND FLEXIBILITY OF AI SOFTWARE TO ENHANCE EFFICIENCY OF CLINICAL WORKFLOWS
8.3.1
NEED FOR EXPERT ASSISTANCE AMONG HEALTHCARE ORGANIZATIONS IN ADOPTING AND OPTIMIZING AI TECHNOLOGIES
9
AI IN PRECISION MEDICINE MARKET, BY TOOL
Market Size & Growth Rate Forecast Analysis to 2030 in USD Million | 18 Data Tables
150
9.2.1.1
CONVOLUTIONAL NEURAL NETWORKS
9.2.1.1.1
INTERPRETING COMPLEX BIOLOGICAL DATA TO ENABLE PERSONALIZING HEALTHCARE
9.2.1.2
RECURRENT NEURAL NETWORKS (RNNS)
9.2.1.2.1
OPTIMIZING CLINICAL DATA TO MODEL PATIENT TRAJECTORIES BY ANALYZING LONGITUDINAL DATA
9.2.1.3
GENERATIVE ADVERSARIAL NETWORKS (GANS)
9.2.1.3.1
GAN TO FOCUS ON NEW MOLECULES AND BIOLOGICAL DATASETS
9.2.1.4
GRAPH NEURAL NETWORKS (GNNS)
9.2.1.4.1
PREDICTING DRUG-DRUG INTERACTIONS TO OPTIMIZE PERSONALIZED TREATMENT
9.2.1.5
OTHER DEEP LEARNING TOOLS
9.2.2
SUPERVISED MACHINE LEARNING
9.2.3
REINFORCEMENT MACHINE LEARNING
9.2.4
UNSUPERVISED MACHINE LEARNING
9.2.5
OTHER MACHINE LEARNING TOOLS
9.3
NATURAL LANGUAGE PROCESSING
9.3.1
ABUNDANCE OF UNSTRUCTURED DATA IN CLINICAL RESEARCH TO BE INTERPRETED
9.4
CONTEXT-AWARE PROCESSING & COMPUTING
9.4.1
TAILORING PATIENT CARE IN REAL TIME TO ENHANCE PRECISION MEDICINE
9.5.1
INCREASE IN USE OF IMAGING BIOMARKERS TO SUPPORT SURGICAL PRECISION
9.6.1
HARNESSING MACHINE LEARNING TO AUTOMATE TECHNIQUES SUCH AS QUANTITATIVE IMAGING AND RADIOMICS
10
ARTIFICIAL INTELLIGENCE IN PRECISION MEDICINE MARKET, BY DEPLOYMENT
Market Size & Growth Rate Forecast Analysis to 2030 in USD Million | 4 Data Tables
168
10.2.1
RESEARCH COLLABORATION AND COST-EFFICIENCY OF CLOUD DEPLOYMENT
10.3.1
EASIER TO SECURE PATIENT DATA AND ENSURE COMPLIANCE IN ON-PREMISE AI-DRIVEN PRECISION MEDICINE
10.4.1
HYBRID MODELS TO ENHANCE FLEXIBILITY AND SECURITY
11
ARTIFICIAL INTELLIGENCE IN PRECISION MEDICINE MARKET, BY END USER
Market Size & Growth Rate Forecast Analysis to 2030 in USD Million | 6 Data Tables
174
11.2
HEALTHCARE PROVIDERS
11.2.1
REVOLUTIONIZING PATIENT CARE AND TREATMENT DELIVERY THROUGH ADVANCED TECHNOLOGIES
11.3
PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES
11.3.1
DRIVING DRUG DEVELOPMENT EFFICIENCY TO DESIGN ADAPTIVE TRIAL PROTOCOLS AND OPTIMIZE TREATMENT
11.4
MEDICAL DEVICE & EQUIPMENT COMPANIES
11.4.1
INTEGRATION OF AI IN MEDICAL DEVICES TO ENHANCE PRECISION AND PERSONALIZED HEALTHCARE
11.5
RESEARCH CENTERS, ACADEMIC INSTITUTES, AND GOVERNMENT ORGANIZATIONS
11.5.1
AI IN ACADEMIC INSTITUTES AND PUBLIC SECTOR COLLABORATIONS TO ACCELERATE INNOVATION AND RESEARCH
12
ARTIFICIAL INTELLIGENCE IN PRECISION MEDICINE MARKET, BY REGION
Comprehensive coverage of 8 Regions with country-level deep-dive of 12 Countries | 138 Data Tables.
181
12.2.1
NORTH AMERICA: MACROECONOMIC OUTLOOK
12.2.2.1
US TO DOMINATE NORTH AMERICAN MARKET WITH ADVANCED REGULATORY SYSTEM
12.2.3.1
EMERGENCE OF NEW AI-BASED STARTUPS AND HIGH HEALTH EXPENDITURE
12.3.1
EUROPE: MACROECONOMIC OUTLOOK
12.3.2.1
FAVORABLE GOVERNMENT R&D INVESTMENT AND COLLABORATIONS FOCUSED ON DRUG DISCOVERY
12.3.3.1
GROWING R&D INVESTMENT BY PHARMA AND BIOTECH COMPANIES
12.3.4.1
STRONG GOVERNMENT SUPPORT THROUGH INVESTMENTS IN INITIATIVES
12.3.5.1
GOVERNMENT INITIATIVES ADDRESSING LOCAL HEALTHCARE CHALLENGES THROUGH STUDIES AIMED AT BROADER PRECISION MEDICINE STRATEGIES
12.3.6.1
HIGH INVESTMENTS BY PHARMACEUTICAL COMPANIES
12.4.1
ASIA PACIFIC: MACROECONOMIC OUTLOOK
12.4.2.1
HIGH INVESTMENT IN R&D AND GOVERNMENT INITIATIVES FOCUSED ON TREATMENT OUTCOMES
12.4.3.1
GOVERNMENT FUNDING TO ADVANCE DATA ANALYSIS AND INTERNATIONAL COLLABORATIONS TO DEVELOP TARGETED THERAPIES
12.4.4.1
HIGH GROWTH OF PHARMACEUTICAL AND MEDICAL DEVICE INDUSTRIES
12.4.5
REST OF ASIA PACIFIC
12.5.1
LATIN AMERICA: MACROECONOMIC OUTLOOK
12.5.2.1
INCREASE IN GOVERNMENTAL SUPPORT THROUGH INITIATIVES SUCH AS BRAZILIAN ARTIFICIAL INTELLIGENCE PLAN
12.5.3.1
HIGH POTENTIAL TO BECOME LEADER IN TERMS OF READINESS IN TECHNOLOGY
12.5.4
REST OF LATIN AMERICA
12.6
MIDDLE EAST & AFRICA
12.6.1
MIDDLE EAST & AFRICA: MACROECONOMIC OUTLOOK
12.6.2.1
INCREASING EMPHASIS ON PERSONALIZED MEDICINES AND DEVELOPING HEALTHCARE INFRASTRUCTURE
12.6.3
REST OF MIDDLE EAST & AFRICA
13
COMPETITIVE LANDSCAPE
Discover market dominance strategies and key player rankings driving competitive advantage.
261
13.2
KEY PLAYER STRATEGY/RIGHT TO WIN
13.3
REVENUE ANALYSIS, 2019–2023
13.4
MARKET SHARE ANALYSIS, 2023
13.4.1
RANKING OF KEY MARKET PLAYERS
13.5
COMPANY EVALUATION MATRIX: KEY PLAYERS, 2023
13.5.5
COMPANY FOOTPRINT: KEY PLAYERS, 2023
13.5.5.1
COMPANY FOOTPRINT
13.5.5.2
THERAPEUTIC AREA FOOTPRINT
13.5.5.3
END USER FOOTPRINT
13.5.5.4
COMPONENT FOOTPRINT
13.5.5.5
DEPLOYMENT FOOTPRINT
13.5.5.6
REGION FOOTPRINT
13.6
COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2023
13.6.1
PROGRESSIVE COMPANIES
13.6.2
RESPONSIVE COMPANIES
13.6.5
COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2023
13.6.5.1
DETAILED LIST OF KEY STARTUP/SME PLAYERS
13.6.5.2
COMPETITIVE BENCHMARKING OF KEY EMERGING PLAYERS/STARTUPS, BY REGION
13.7
COMPANY VALUATION AND FINANCIAL METRICS
13.8
BRAND/PRODUCT COMPARISON
13.9
COMPETITIVE SCENARIO
13.9.4
OTHER DEVELOPMENTS
14
COMPANY PROFILES
In-depth Company Profiles of Leading Market Players with detailed Business Overview, Product and Service Portfolio, Recent Developments, and Unique Analyst Perspective (MnM View)
287
14.1.1
NVIDIA CORPORATION
14.1.1.1
BUSINESS OVERVIEW
14.1.1.2
PRODUCTS/SERVICES/SOLUTIONS OFFERED
14.1.1.3
RECENT DEVELOPMENTS
14.1.1.3.1
PRODUCT LAUNCHES
14.1.1.4.2
STRATEGIC CHOICES
14.1.1.4.3
WEAKNESSES & COMPETITIVE THREATS
14.1.7
MICROSOFT CORPORATION
14.1.11
SIEMENS HEALTHINEERS AG
14.1.12
BIOXCEL THERAPEUTICS, INC.
14.1.13
INSILICO MEDICINE
14.1.16
GUARDANT HEALTH, INC.
14.1.18
FOUNDATION MEDICINE, INC.
14.2.1
PREDICTIVE ONCOLOGY
15.2
KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
15.3
CUSTOMIZATION OPTIONS
TABLE 1
AI IN PRECISION MEDICINE MARKET: INCLUSIONS & EXCLUSIONS
TABLE 2
ARTIFICIAL INTELLIGENCE IN PRECISION MEDICINE MARKET DYNAMICS: IMPACT ANALYSIS
TABLE 3
INDICATIVE LIST OF COLLABORATIONS AND PARTNERSHIPS, 2021–2024
TABLE 4
BIGGEST HEALTHCARE SECURITY BREACHES, 2023
TABLE 5
AI IN DRUG DISCOVERY MARKET: ROLE IN ECOSYSTEM
TABLE 6
NORTH AMERICA: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 7
EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 9
ASIA PACIFIC: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 10
LATIN AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 11
MIDDLE EAST & AFRICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 12
NORTH AMERICA: REGULATORY SCENARIO
TABLE 13
EUROPE: REGULATORY SCENARIO
TABLE 14
ASIA PACIFIC: REGULATORY SCENARIO
TABLE 15
MIDDLE EAST & AFRICA: REGULATORY SCENARIO
TABLE 16
LATIN AMERICA: REGULATORY SCENARIO
TABLE 17
INDICATIVE PRICING FOR KEY PLAYERS, 2023 (USD)
TABLE 18
INDICATIVE PRICE OF KEY COMPONENTS, BY REGION, 2022–2024 (USD)
TABLE 19
AI IN PRECISION MEDICINE MARKET: PORTER’S FIVE FORCES ANALYSIS
TABLE 20
JURISDICTION ANALYSIS OF TOP APPLICANT COUNTRIES FOR AI IN PRECISION MEDICINE
TABLE 21
AI IN PRECISION MEDICINE MARKET: LIST OF PATENTS/PATENT APPLICATIONS
TABLE 22
INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS OF TOP THREE END USERS
TABLE 23
KEY BUYING CRITERIA FOR TOP THREE END USERS
TABLE 24
UNMET NEEDS IN AI IN PRECISION MEDICINE MARKET
TABLE 25
END-USER EXPECTATIONS IN AI IN PRECISION MEDICINE MARKET
TABLE 26
KEY CONFERENCES & EVENTS, 2024–2025
TABLE 27
ARTIFICIAL INTELLIGENCE IN PRECISION MEDICINE MARKET, BY APPLICATION, 2022–2030 (USD MILLION)
TABLE 28
ARTIFICIAL INTELLIGENCE IN PRECISION MEDICINE MARKET FOR DRUG DISCOVERY & DEVELOPMENT, BY APPLICATION, 2022–2030 (USD MILLION)
TABLE 29
ARTIFICIAL INTELLIGENCE IN PRECISION MEDICINE MARKET FOR DRUG DISCOVERY, BY APPLICATION, 2022–2030 (USD MILLION)
TABLE 30
ARTIFICIAL INTELLIGENCE IN PRECISION MEDICINE MARKET FOR UNDERSTANDING DISEASES, BY COUNTRY/REGION, 2022–2030 (USD MILLION)
TABLE 31
ARTIFICIAL INTELLIGENCE IN PRECISION MEDICINE MARKET FOR DRUG REPURPOSING, BY COUNTRY/REGION, 2022–2030 (USD MILLION)
TABLE 32
ARTIFICIAL INTELLIGENCE IN PRECISION MEDICINE MARKET FOR DE NOVO DRUG DESIGN, BY COUNTRY/REGION, 2022–2030 (USD MILLION)
TABLE 33
ARTIFICIAL INTELLIGENCE IN PRECISION MEDICINE MARKET FOR DRUG OPTIMIZATION, BY COUNTRY/REGION, 2022–2030 (USD MILLION)
TABLE 34
ARTIFICIAL INTELLIGENCE IN PRECISION MEDICINE MARKET FOR SAFETY & TOXICITY, BY COUNTRY/REGION, 2022–2030 (USD MILLION)
TABLE 35
ARTIFICIAL INTELLIGENCE IN PRECISION MEDICINE MARKET FOR CLINICAL DEVELOPMENT, BY COUNTRY/REGION, 2022–2030 (USD MILLION)
TABLE 36
ARTIFICIAL INTELLIGENCE IN PRECISION MEDICINE MARKET FOR DIAGNOSTICS & SCREENING, BY TYPE, 2022–2030 (USD MILLION)
TABLE 37
ARTIFICIAL INTELLIGENCE IN PRECISION MEDICINE MARKET FOR RISK ASSESSMENT & PATIENT STRATIFICATION, BY COUNTRY/REGION, 2022–2030 (USD MILLION)
TABLE 38
ARTIFICIAL INTELLIGENCE IN PRECISION MEDICINE MARKET FOR DISEASE SCREENING, BY COUNTRY/REGION, 2022–2030 (USD MILLION)
TABLE 39
ARTIFICIAL INTELLIGENCE IN PRECISION MEDICINE MARKET FOR DISEASE DIAGNOSIS, BY COUNTRY/REGION, 2022–2030 (USD MILLION)
TABLE 40
ARTIFICIAL INTELLIGENCE IN PRECISION MEDICINE MARKET FOR DISEASE PROGRESSION, STAGING, AND PROGNOSIS, BY COUNTRY/REGION, 2022–2030 (USD MILLION)
TABLE 41
ARTIFICIAL INTELLIGENCE IN PRECISION MEDICINE MARKET FOR THERAPEUTICS, BY TYPE, 2022–2030 (USD MILLION)
TABLE 42
ARTIFICIAL INTELLIGENCE IN PRECISION MEDICINE MARKET FOR THERAPY SELECTION & PLANNING, BY COUNTRY/REGION, 2022–2030 (USD MILLION)
TABLE 43
ARTIFICIAL INTELLIGENCE IN PRECISION MEDICINE MARKET FOR THERAPY MONITORING, BY COUNTRY/REGION, 2022–2030 (USD MILLION)
TABLE 44
ARTIFICIAL INTELLIGENCE IN PRECISION MEDICINE MARKET FOR POST-TREATMENT SURVEILLANCE & FOLLOW-UP, BY COUNTRY/REGION, 2022–2030 (USD MILLION)
TABLE 45
ARTIFICIAL INTELLIGENCE IN PRECISION MEDICINE MARKET, BY THERAPEUTIC AREA, 2022–2030 (USD MILLION)
TABLE 46
ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET FOR ONCOLOGY, BY COUNTRY/REGION, 2022–2030 (USD MILLION)
TABLE 47
ARTIFICIAL INTELLIGENCE IN PRECISION MEDICINE MARKET FOR RARE DISEASES, BY COUNTRY/REGION, 2022–2030 (USD MILLION)
TABLE 48
ARTIFICIAL INTELLIGENCE IN PRECISION MEDICINE MARKET FOR INFECTIOUS DISEASES, BY COUNTRY/REGION, 2022–2030 (USD MILLION)
TABLE 49
ARTIFICIAL INTELLIGENCE IN PRECISION MEDICINE MARKET FOR NEUROLOGY, BY COUNTRY/REGION, 2022–2030 (USD MILLION)
TABLE 50
INDICATIVE LIST OF DEVELOPMENTS IN CARDIOLOGY
TABLE 51
ARTIFICIAL INTELLIGENCE IN PRECISION MEDICINE MARKET FOR CARDIOLOGY, BY COUNTRY/REGION, 2022–2030 (USD MILLION)
TABLE 52
ARTIFICIAL INTELLIGENCE IN PRECISION MEDICINE MARKET FOR HEMATOLOGY, BY COUNTRY/REGION, 2022–2030 (USD MILLION)
TABLE 53
ARTIFICIAL INTELLIGENCE IN PRECISION MEDICINE MARKET FOR OTHER THERAPEUTIC AREAS, BY COUNTRY/REGION, 2022–2030 (USD MILLION)
TABLE 54
ARTIFICIAL INTELLIGENCE IN PRECISION MEDICINE MARKET, BY COMPONENT, 2022–2030 (USD MILLION)
TABLE 55
ARTIFICIAL INTELLIGENCE IN PRECISION MEDICINE MARKET FOR SOFTWARE, BY COUNTRY/REGION, 2022–2030 (USD MILLION)
TABLE 56
ARTIFICIAL INTELLIGENCE SERVICES IN PRECISION MEDICINE MARKET, BY COUNTRY/REGION, 2022–2030 (USD MILLION)
TABLE 57
AI IN PRECISION MEDICINE MARKET, BY TOOL, 2022–2030 (USD MILLION)
TABLE 58
MACHINE LEARNING IN PRECISION MEDICINE MARKET, BY TYPE, 2022–2030 (USD MILLION)
TABLE 59
MACHINE LEARNING IN PRECISION MEDICINE MARKET, BY COUNTRY/REGION, 2022–2030 (USD MILLION)
TABLE 60
DEEP LEARNING IN PRECISION MEDICINE MARKET, BY COUNTRY/REGION, 2022–2030 (USD MILLION)
TABLE 61
CONVOLUTIONAL NEURAL NETWORKS IN PRECISION MEDICINE MARKET, BY COUNTRY/REGION, 2022–2030 (USD MILLION)
TABLE 62
RECURRENT NEURAL NETWORKS IN PRECISION MEDICINE MARKET, BY COUNTRY/REGION, 2022–2030 (USD MILLION)
TABLE 63
GENERATIVE ADVERSARIAL NETWORKS IN PRECISION MEDICINE MARKET, BY COUNTRY/REGION, 2022–2030 (USD MILLION)
TABLE 64
GRAPH NEURAL NETWORKS IN PRECISION MEDICINE MARKET, BY COUNTRY/REGION, 2022–2030 (USD MILLION)
TABLE 65
OTHER DEEP LEARNING TOOLS IN PRECISION MEDICINE MARKET, BY COUNTRY/REGION, 2022–2030 (USD MILLION)
TABLE 66
SUPERVISED LEARNING IN PRECISION MEDICINE MARKET, BY COUNTRY/REGION, 2022–2030 (USD MILLION)
TABLE 67
REINFORCEMENT LEARNING IN PRECISION MEDICINE MARKET, BY COUNTRY/REGION, 2022–2030 (USD MILLION)
TABLE 68
UNSUPERVISED LEARNING IN PRECISION MEDICINE MARKET, BY COUNTRY/REGION, 2022–2030 (USD MILLION)
TABLE 69
OTHER MACHINE LEARNING TOOLS IN PRECISION MEDICINE MARKET, BY COUNTRY/REGION, 2022–2030 (USD MILLION)
TABLE 70
NATURAL LANGUAGE PROCESSING IN PRECISION MEDICINE MARKET, BY COUNTRY/REGION, 2022–2030 (USD MILLION)
TABLE 71
CONTEXT-AWARE PROCESSING & COMPUTING IN PRECISION MEDICINE MARKET, BY COUNTRY/REGION, 2022–2030 (USD MILLION)
TABLE 72
COMPUTER VISION AI IN PRECISION MEDICINE MARKET, BY COUNTRY/REGION, 2022–2030 (USD MILLION)
TABLE 73
IMAGE ANALYSIS IN PRECISION MEDICINE MARKET, BY COUNTRY/REGION, 2022–2030 (USD MILLION)
TABLE 74
OTHER AI TOOLS IN PRECISION MEDICINE MARKET, BY COUNTRY/REGION, 2022–2030 (USD MILLION)
TABLE 75
ARTIFICIAL INTELLIGENCE IN PRECISION MEDICINE MARKET, BY DEPLOYMENT, 2022–2030 (USD MILLION)
TABLE 76
ARTIFICIAL INTELLIGENCE IN PRECISION MEDICINE MARKET FOR CLOUD-BASED MODEL, BY COUNTRY/REGION, 2022–2030 (USD MILLION)
TABLE 77
ARTIFICIAL INTELLIGENCE IN PRECISION MEDICINE MARKET FOR ON-PREMISE MODEL, BY COUNTRY/REGION, 2022–2030 (USD MILLION)
TABLE 78
ARTIFICIAL INTELLIGENCE IN PRECISION MEDICINE MARKET FOR HYBRID MODEL, BY COUNTRY/REGION, 2022–2030 (USD MILLION)
TABLE 79
ARTIFICIAL INTELLIGENCE IN PRECISION MEDICINE MARKET, BY END USER, 2022–2030 (USD MILLION)
TABLE 80
ARTIFICIAL INTELLIGENCE IN PRECISION MEDICINE MARKET FOR HEALTHCARE PROVIDERS, BY COUNTRY/REGION, 2022–2030 (USD MILLION)
TABLE 81
ARTIFICIAL INTELLIGENCE IN PRECISION MEDICINE MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY/REGION, 2022–2030 (USD MILLION)
TABLE 82
ARTIFICIAL INTELLIGENCE IN PRECISION MEDICINE MARKET FOR MEDICAL DEVICE & EQUIPMENT COMPANIES, BY COUNTRY/REGION, 2022–2030 (USD MILLION)
TABLE 83
ARTIFICIAL INTELLIGENCE IN PRECISION MEDICINE MARKET FOR RESEARCH CENTERS, ACADEMIC INSTITUTES, AND GOVERNMENT ORGANIZATIONS, BY COUNTRY/REGION, 2022–2030 (USD MILLION)
TABLE 84
ARTIFICIAL INTELLIGENCE IN PRECISION MEDICINE MARKET FOR OTHER END USERS, BY COUNTRY/REGION, 2022–2030 (USD MILLION)
TABLE 85
ARTIFICIAL INTELLIGENCE IN PRECISION MEDICINE MARKET, BY REGION, 2022–2030 (USD MILLION)
TABLE 86
NORTH AMERICA: ARTIFICIAL INTELLIGENCE IN PRECISION MEDICINE MARKET, BY COUNTRY, 2022–2030 (USD MILLION)
TABLE 87
NORTH AMERICA: ARTIFICIAL INTELLIGENCE IN PRECISION MEDICINE MARKET, BY APPLICATION, 2022–2030 (USD MILLION)
TABLE 88
NORTH AMERICA: ARTIFICIAL INTELLIGENCE IN PRECISION MEDICINE MARKET, BY THERAPEUTIC AREA, 2022–2030 (USD MILLION)
TABLE 89
NORTH AMERICA: ARTIFICIAL INTELLIGENCE IN PRECISION MEDICINE MARKET, BY COMPONENT, 2022–2030 (USD MILLION)
TABLE 90
NORTH AMERICA: ARTIFICIAL INTELLIGENCE IN PRECISION MEDICINE MARKET, BY TOOL, 2022–2030 (USD MILLION)
TABLE 91
NORTH AMERICA: ARTIFICIAL INTELLIGENCE IN PRECISION MEDICINE MARKET, BY DEPLOYMENT 2022–2030 (USD MILLION)
TABLE 92
NORTH AMERICA: ARTIFICIAL INTELLIGENCE IN PRECISION MEDICINE MARKET, BY END USER, 2022–2030 (USD MILLION)
TABLE 93
US: ARTIFICIAL INTELLIGENCE IN PRECISION MEDICINE MARKET, BY APPLICATION, 2022–2030 (USD MILLION)
TABLE 94
US: ARTIFICIAL INTELLIGENCE IN PRECISION MEDICINE MARKET, BY THERAPEUTIC AREA, 2022–2030 (USD MILLION)
TABLE 95
US: ARTIFICIAL INTELLIGENCE IN PRECISION MEDICINE MARKET, BY COMPONENT, 2022–2030 (USD MILLION)
TABLE 96
US: ARTIFICIAL INTELLIGENCE IN PRECISION MEDICINE MARKET, BY TOOL, 2022–2030 (USD MILLION)
TABLE 97
US: ARTIFICIAL INTELLIGENCE IN PRECISION MEDICINE MARKET, BY DEPLOYMENT 2022–2030 (USD MILLION)
TABLE 98
US: ARTIFICIAL INTELLIGENCE IN PRECISION MEDICINE MARKET, BY END USER, 2022–2030 (USD MILLION)
TABLE 99
CANADA: ARTIFICIAL INTELLIGENCE IN PRECISION MEDICINE MARKET, BY APPLICATION, 2022–2030 (USD MILLION)
TABLE 100
CANADA: ARTIFICIAL INTELLIGENCE IN PRECISION MEDICINE MARKET, BY THERAPEUTIC AREA, 2022–2030 (USD MILLION)
TABLE 101
CANADA: ARTIFICIAL INTELLIGENCE IN PRECISION MEDICINE MARKET, BY COMPONENT, 2022–2030 (USD MILLION)
TABLE 102
CANADA: ARTIFICIAL INTELLIGENCE IN PRECISION MEDICINE MARKET, BY TOOL, 2022–2030 (USD MILLION)
TABLE 103
CANADA: ARTIFICIAL INTELLIGENCE IN PRECISION MEDICINE MARKET, BY DEPLOYMENT 2022–2030 (USD MILLION)
TABLE 104
CANADA: ARTIFICIAL INTELLIGENCE IN PRECISION MEDICINE MARKET, BY END USER, 2022–2030 (USD MILLION)
TABLE 105
EUROPE: ARTIFICIAL INTELLIGENCE IN PRECISION MEDICINE MARKET, BY COUNTRY, 2022–2030 (USD MILLION)
TABLE 106
EUROPE: ARTIFICIAL INTELLIGENCE IN PRECISION MEDICINE MARKET, BY APPLICATION, 2022–2030 (USD MILLION)
TABLE 107
EUROPE: ARTIFICIAL INTELLIGENCE IN PRECISION MEDICINE MARKET, BY THERAPEUTIC AREA, 2022–2030 (USD MILLION)
TABLE 108
EUROPE: ARTIFICIAL INTELLIGENCE IN PRECISION MEDICINE MARKET, BY COMPONENT, 2022–2030 (USD MILLION)
TABLE 109
EUROPE: ARTIFICIAL INTELLIGENCE IN PRECISION MEDICINE MARKET, BY TOOL, 2022–2030 (USD MILLION)
TABLE 110
EUROPE: ARTIFICIAL INTELLIGENCE IN PRECISION MEDICINE MARKET, BY DEPLOYMENT, 2022–2030 (USD MILLION)
TABLE 111
EUROPE: ARTIFICIAL INTELLIGENCE IN PRECISION MEDICINE MARKET, BY END USER, 2022–2030 (USD MILLION)
TABLE 112
UK: ARTIFICIAL INTELLIGENCE IN PRECISION MEDICINE MARKET, BY APPLICATION, 2022–2030 (USD MILLION)
TABLE 113
UK: ARTIFICIAL INTELLIGENCE IN PRECISION MEDICINE MARKET, BY THERAPEUTIC AREA, 2022–2030 (USD MILLION)
TABLE 114
UK: ARTIFICIAL INTELLIGENCE IN PRECISION MEDICINE MARKET, BY COMPONENT, 2022–2030 (USD MILLION)
TABLE 115
UK: ARTIFICIAL INTELLIGENCE IN PRECISION MEDICINE MARKET, BY TOOL, 2022–2030 (USD MILLION)
TABLE 116
UK: ARTIFICIAL INTELLIGENCE IN PRECISION MEDICINE MARKET, BY DEPLOYMENT, 2022–2030 (USD MILLION)
TABLE 117
UK: ARTIFICIAL INTELLIGENCE IN PRECISION MEDICINE MARKET, BY END USER, 2022–2030 (USD MILLION)
TABLE 118
GERMANY: ARTIFICIAL INTELLIGENCE IN PRECISION MEDICINE MARKET, BY APPLICATION, 2022–2030 (USD MILLION)
TABLE 119
GERMANY: ARTIFICIAL INTELLIGENCE IN PRECISION MEDICINE MARKET, BY THERAPEUTIC AREA, 2022–2030 (USD MILLION)
TABLE 120
GERMANY: ARTIFICIAL INTELLIGENCE IN PRECISION MEDICINE MARKET, BY COMPONENT, 2022–2030 (USD MILLION)
TABLE 121
GERMANY: ARTIFICIAL INTELLIGENCE IN PRECISION MEDICINE MARKET, BY TOOL, 2022–2030 (USD MILLION)
TABLE 122
GERMANY: ARTIFICIAL INTELLIGENCE IN PRECISION MEDICINE MARKET, BY DEPLOYMENT, 2022–2030 (USD MILLION)
TABLE 123
GERMANY: ARTIFICIAL INTELLIGENCE IN PRECISION MEDICINE MARKET, BY END USER, 2022–2030 (USD MILLION)
TABLE 124
FRANCE: ARTIFICIAL INTELLIGENCE IN PRECISION MEDICINE MARKET, BY APPLICATION, 2022–2030 (USD MILLION)
TABLE 125
FRANCE: ARTIFICIAL INTELLIGENCE IN PRECISION MEDICINE MARKET, BY THERAPEUTIC AREA, 2022–2030 (USD MILLION)
TABLE 126
FRANCE: ARTIFICIAL INTELLIGENCE IN PRECISION MEDICINE MARKET, BY COMPONENT, 2022–2030 (USD MILLION)
TABLE 127
FRANCE: ARTIFICIAL INTELLIGENCE IN PRECISION MEDICINE MARKET, BY TOOL, 2022–2030 (USD MILLION)
TABLE 128
FRANCE: ARTIFICIAL INTELLIGENCE IN PRECISION MEDICINE MARKET, BY DEPLOYMENT, 2022–2030 (USD MILLION)
TABLE 129
FRANCE: ARTIFICIAL INTELLIGENCE IN PRECISION MEDICINE MARKET, BY END USER, 2022–2030 (USD MILLION)
TABLE 130
ITALY: ARTIFICIAL INTELLIGENCE IN PRECISION MEDICINE MARKET, BY APPLICATION, 2022–2030 (USD MILLION)
TABLE 131
ITALY: ARTIFICIAL INTELLIGENCE IN PRECISION MEDICINE MARKET, BY THERAPEUTIC AREA, 2022–2030 (USD MILLION)
TABLE 132
ITALY: ARTIFICIAL INTELLIGENCE IN PRECISION MEDICINE MARKET, BY COMPONENT, 2022–2030 (USD MILLION)
TABLE 133
ITALY: ARTIFICIAL INTELLIGENCE IN PRECISION MEDICINE MARKET, BY TOOL, 2022–2030 (USD MILLION)
TABLE 134
ITALY: ARTIFICIAL INTELLIGENCE IN PRECISION MEDICINE MARKET, BY DEPLOYMENT, 2022–2030 (USD MILLION)
TABLE 135
ITALY: ARTIFICIAL INTELLIGENCE IN PRECISION MEDICINE MARKET, BY END USER, 2022–2030 (USD MILLION)
TABLE 136
SPAIN: ARTIFICIAL INTELLIGENCE IN PRECISION MEDICINE MARKET, BY APPLICATION, 2022–2030 (USD MILLION)
TABLE 137
SPAIN: ARTIFICIAL INTELLIGENCE IN PRECISION MEDICINE MARKET, BY THERAPEUTIC AREA, 2022–2030 (USD MILLION)
TABLE 138
SPAIN: ARTIFICIAL INTELLIGENCE IN PRECISION MEDICINE MARKET, BY COMPONENT, 2022–2030 (USD MILLION)
TABLE 139
SPAIN: ARTIFICIAL INTELLIGENCE IN PRECISION MEDICINE MARKET, BY TOOL, 2022–2030 (USD MILLION)
TABLE 140
SPAIN: ARTIFICIAL INTELLIGENCE IN PRECISION MEDICINE MARKET, BY DEPLOYMENT, 2022–2030 (USD MILLION)
TABLE 141
SPAIN: ARTIFICIAL INTELLIGENCE IN PRECISION MEDICINE MARKET, BY END USER, 2022–2030 (USD MILLION)
TABLE 142
REST OF EUROPE: ARTIFICIAL INTELLIGENCE IN PRECISION MEDICINE MARKET, BY APPLICATION, 2022–2030 (USD MILLION)
TABLE 143
REST OF EUROPE: ARTIFICIAL INTELLIGENCE IN PRECISION MEDICINE MARKET, BY THERAPEUTIC AREA, 2022–2030 (USD MILLION)
TABLE 144
REST OF EUROPE: ARTIFICIAL INTELLIGENCE IN PRECISION MEDICINE MARKET, BY COMPONENT, 2022–2030 (USD MILLION)
TABLE 145
REST OF EUROPE: ARTIFICIAL INTELLIGENCE IN PRECISION MEDICINE MARKET, BY TOOL, 2022–2030 (USD MILLION)
TABLE 146
REST OF EUROPE: ARTIFICIAL INTELLIGENCE IN PRECISION MEDICINE MARKET, BY DEPLOYMENT, 2022–2030 (USD MILLION)
TABLE 147
REST OF EUROPE: ARTIFICIAL INTELLIGENCE IN PRECISION MEDICINE MARKET, BY END USER, 2022–2030 (USD MILLION)
TABLE 148
ASIA PACIFIC: ARTIFICIAL INTELLIGENCE IN PRECISION MEDICINE MARKET, BY COUNTRY, 2022–2030 (USD MILLION)
TABLE 149
ASIA PACIFIC: ARTIFICIAL INTELLIGENCE IN PRECISION MEDICINE MARKET, BY APPLICATION, 2022–2030 (USD MILLION)
TABLE 150
ASIA PACIFIC: ARTIFICIAL INTELLIGENCE IN PRECISION MEDICINE MARKET, BY THERAPEUTIC AREA, 2022–2030 (USD MILLION)
TABLE 151
ASIA PACIFIC: ARTIFICIAL INTELLIGENCE IN PRECISION MEDICINE MARKET, BY COMPONENT, 2022–2030 (USD MILLION)
TABLE 152
ASIA PACIFIC: ARTIFICIAL INTELLIGENCE IN PRECISION MEDICINE MARKET, BY TOOL, 2022–2030 (USD MILLION)
TABLE 153
ASIA PACIFIC: ARTIFICIAL INTELLIGENCE IN PRECISION MEDICINE MARKET, BY DEPLOYMENT, 2022–2030 (USD MILLION)
TABLE 154
ASIA PACIFIC: ARTIFICIAL INTELLIGENCE IN PRECISION MEDICINE MARKET, BY END USER, 2022–2030 (USD MILLION)
TABLE 155
JAPAN: ARTIFICIAL INTELLIGENCE IN PRECISION MEDICINE MARKET, BY APPLICATION, 2022–2030 (USD MILLION)
TABLE 156
JAPAN: ARTIFICIAL INTELLIGENCE IN PRECISION MEDICINE MARKET, BY THERAPEUTIC AREA, 2022–2030 (USD MILLION)
TABLE 157
JAPAN: ARTIFICIAL INTELLIGENCE IN PRECISION MEDICINE MARKET, BY COMPONENT, 2022–2030 (USD MILLION)
TABLE 158
JAPAN: ARTIFICIAL INTELLIGENCE IN PRECISION MEDICINE MARKET, BY TOOL, 2022–2030 (USD MILLION)
TABLE 159
JAPAN: ARTIFICIAL INTELLIGENCE IN PRECISION MEDICINE MARKET, BY DEPLOYMENT, 2022–2030 (USD MILLION)
TABLE 160
JAPAN: ARTIFICIAL INTELLIGENCE IN PRECISION MEDICINE MARKET, BY END USER, 2022–2030 (USD MILLION)
TABLE 161
CHINA: ARTIFICIAL INTELLIGENCE IN PRECISION MEDICINE MARKET, BY APPLICATION, 2022–2030 (USD MILLION)
TABLE 162
CHINA: ARTIFICIAL INTELLIGENCE IN PRECISION MEDICINE MARKET, BY THERAPEUTIC AREA, 2022–2030 (USD MILLION)
TABLE 163
CHINA: ARTIFICIAL INTELLIGENCE IN PRECISION MEDICINE MARKET, BY COMPONENT, 2022–2030 (USD MILLION)
TABLE 164
CHINA: ARTIFICIAL INTELLIGENCE IN PRECISION MEDICINE MARKET, BY TOOL, 2022–2030 (USD MILLION)
TABLE 165
CHINA: ARTIFICIAL INTELLIGENCE IN PRECISION MEDICINE MARKET, BY DEPLOYMENT, 2022–2030 (USD MILLION)
TABLE 166
CHINA: ARTIFICIAL INTELLIGENCE IN PRECISION MEDICINE MARKET, BY END USER, 2022–2030 (USD MILLION)
TABLE 167
INDIA: ARTIFICIAL INTELLIGENCE IN PRECISION MEDICINE MARKET, BY APPLICATION, 2022–2030 (USD MILLION)
TABLE 168
INDIA: ARTIFICIAL INTELLIGENCE IN PRECISION MEDICINE MARKET, BY THERAPEUTIC AREA, 2022–2030 (USD MILLION)
TABLE 169
INDIA: ARTIFICIAL INTELLIGENCE IN PRECISION MEDICINE MARKET, BY COMPONENT, 2022–2030 (USD MILLION)
TABLE 170
INDIA: ARTIFICIAL INTELLIGENCE IN PRECISION MEDICINE MARKET, BY TOOL, 2022–2030 (USD MILLION)
TABLE 171
INDIA: ARTIFICIAL INTELLIGENCE IN PRECISION MEDICINE MARKET, BY DEPLOYMENT, 2022–2030 (USD MILLION)
TABLE 172
INDIA: ARTIFICIAL INTELLIGENCE IN PRECISION MEDICINE MARKET, BY END USER, 2022–2030 (USD MILLION)
TABLE 173
REST OF ASIA PACIFIC: ARTIFICIAL INTELLIGENCE IN PRECISION MEDICINE MARKET, BY APPLICATION, 2022–2030 (USD MILLION)
TABLE 174
REST OF ASIA PACIFIC: ARTIFICIAL INTELLIGENCE IN PRECISION MEDICINE MARKET, BY THERAPEUTIC AREA, 2022–2030 (USD MILLION)
TABLE 175
REST OF ASIA PACIFIC: ARTIFICIAL INTELLIGENCE IN PRECISION MEDICINE MARKET, BY COMPONENT, 2022–2030 (USD MILLION)
TABLE 176
REST OF ASIA PACIFIC: ARTIFICIAL INTELLIGENCE IN PRECISION MEDICINE MARKET, BY TOOL, 2022–2030 (USD MILLION)
TABLE 177
REST OF ASIA PACIFIC: ARTIFICIAL INTELLIGENCE IN PRECISION MEDICINE MARKET, BY DEPLOYMENT, 2022–2030 (USD MILLION)
TABLE 178
REST OF ASIA PACIFIC: ARTIFICIAL INTELLIGENCE IN PRECISION MEDICINE MARKET, BY END USER, 2022–2030 (USD MILLION)
TABLE 179
LATIN AMERICA: ARTIFICIAL INTELLIGENCE IN PRECISION MEDICINE MARKET, BY REGION, 2022–2030 (USD MILLION)
TABLE 180
LATIN AMERICA: ARTIFICIAL INTELLIGENCE IN PRECISION MEDICINE MARKET, BY APPLICATION, 2022–2030 (USD MILLION)
TABLE 181
LATIN AMERICA: ARTIFICIAL INTELLIGENCE IN PRECISION MEDICINE MARKET, BY THERAPEUTIC AREA, 2022–2030 (USD MILLION)
TABLE 182
LATIN AMERICA: ARTIFICIAL INTELLIGENCE IN PRECISION MEDICINE MARKET, BY COMPONENT, 2022–2030 (USD MILLION)
TABLE 183
LATIN AMERICA: ARTIFICIAL INTELLIGENCE IN PRECISION MEDICINE MARKET, BY TOOL, 2022–2030 (USD MILLION)
TABLE 184
LATIN AMERICA: ARTIFICIAL INTELLIGENCE IN PRECISION MEDICINE MARKET, BY DEPLOYMENT, 2022–2030 (USD MILLION)
TABLE 185
LATIN AMERICA: ARTIFICIAL INTELLIGENCE IN PRECISION MEDICINE MARKET, BY END USER, 2022–2030 (USD MILLION)
TABLE 186
BRAZIL: ARTIFICIAL INTELLIGENCE IN PRECISION MEDICINE MARKET, BY APPLICATION, 2022–2030 (USD MILLION)
TABLE 187
BRAZIL: ARTIFICIAL INTELLIGENCE IN PRECISION MEDICINE MARKET, BY THERAPEUTIC AREA, 2022–2030 (USD MILLION)
TABLE 188
BRAZIL: ARTIFICIAL INTELLIGENCE IN PRECISION MEDICINE MARKET, BY COMPONENT, 2022–2030 (USD MILLION)
TABLE 189
BRAZIL: ARTIFICIAL INTELLIGENCE IN PRECISION MEDICINE MARKET, BY TOOL, 2022–2030 (USD MILLION)
TABLE 190
BRAZIL: ARTIFICIAL INTELLIGENCE IN PRECISION MEDICINE MARKET, BY DEPLOYMENT, 2022–2030 (USD MILLION)
TABLE 191
BRAZIL: ARTIFICIAL INTELLIGENCE IN PRECISION MEDICINE MARKET, BY END USER, 2022–2030 (USD MILLION)
TABLE 192
MEXICO: ARTIFICIAL INTELLIGENCE IN PRECISION MEDICINE MARKET, BY APPLICATION, 2022–2030 (USD MILLION)
TABLE 193
MEXICO: ARTIFICIAL INTELLIGENCE IN PRECISION MEDICINE MARKET, BY THERAPEUTIC AREA, 2022–2030 (USD MILLION)
TABLE 194
MEXICO: ARTIFICIAL INTELLIGENCE IN PRECISION MEDICINE MARKET, BY COMPONENT, 2022–2030 (USD MILLION)
TABLE 195
MEXICO: ARTIFICIAL INTELLIGENCE IN PRECISION MEDICINE MARKET, BY TOOL, 2022–2030 (USD MILLION)
TABLE 196
MEXICO: ARTIFICIAL INTELLIGENCE IN PRECISION MEDICINE MARKET, BY DEPLOYMENT, 2022–2030 (USD MILLION)
TABLE 197
MEXICO: ARTIFICIAL INTELLIGENCE IN PRECISION MEDICINE MARKET, BY END USER, 2022–2030 (USD MILLION)
TABLE 198
REST OF LATIN AMERICA: ARTIFICIAL INTELLIGENCE IN PRECISION MEDICINE MARKET, BY APPLICATION, 2022–2030 (USD MILLION)
TABLE 199
REST OF LATIN AMERICA: ARTIFICIAL INTELLIGENCE IN PRECISION MEDICINE MARKET, BY THERAPEUTIC AREA, 2022–2030 (USD MILLION)
TABLE 200
REST OF LATIN AMERICA: ARTIFICIAL INTELLIGENCE IN PRECISION MEDICINE MARKET, BY COMPONENT, 2022–2030 (USD MILLION)
TABLE 201
REST OF LATIN AMERICA: ARTIFICIAL INTELLIGENCE IN PRECISION MEDICINE MARKET, BY TOOL, 2022–2030 (USD MILLION)
TABLE 202
REST OF LATIN AMERICA: ARTIFICIAL INTELLIGENCE IN PRECISION MEDICINE MARKET, BY DEPLOYMENT, 2022–2030 (USD MILLION)
TABLE 203
REST OF LATIN AMERICA: ARTIFICIAL INTELLIGENCE IN PRECISION MEDICINE MARKET, BY END USER, 2022–2030 (USD MILLION)
TABLE 204
MIDDLE EAST & AFRICA: ARTIFICIAL INTELLIGENCE IN PRECISION MEDICINE MARKET, BY REGION, 2022–2030 (USD MILLION)
TABLE 205
MIDDLE EAST & AFRICA: ARTIFICIAL INTELLIGENCE IN PRECISION MEDICINE MARKET, BY APPLICATION, 2022–2030 (USD MILLION)
TABLE 206
MIDDLE EAST & AFRICA: ARTIFICIAL INTELLIGENCE IN PRECISION MEDICINE MARKET, BY THERAPEUTIC AREA, 2022–2030 (USD MILLION)
TABLE 207
MIDDLE EAST & AFRICA: ARTIFICIAL INTELLIGENCE IN PRECISION MEDICINE MARKET, BY COMPONENT, 2022–2030 (USD MILLION)
TABLE 208
MIDDLE EAST & AFRICA: ARTIFICIAL INTELLIGENCE IN PRECISION MEDICINE MARKET, BY TOOL, 2022–2030 (USD MILLION)
TABLE 209
MIDDLE EAST & AFRICA: ARTIFICIAL INTELLIGENCE IN PRECISION MEDICINE MARKET, BY DEPLOYMENT, 2022–2030 (USD MILLION)
TABLE 210
MIDDLE EAST & AFRICA: ARTIFICIAL INTELLIGENCE IN PRECISION MEDICINE MARKET, BY END USER, 2022–2030 (USD MILLION)
TABLE 211
GCC COUNTRIES: ARTIFICIAL INTELLIGENCE IN PRECISION MEDICINE MARKET, BY APPLICATION, 2022–2030 (USD MILLION)
TABLE 212
GCC COUNTRIES: ARTIFICIAL INTELLIGENCE IN PRECISION MEDICINE MARKET, BY THERAPEUTIC AREA, 2022–2030 (USD MILLION)
TABLE 213
GCC COUNTRIES: ARTIFICIAL INTELLIGENCE IN PRECISION MEDICINE MARKET, BY COMPONENT, 2022–2030 (USD MILLION)
TABLE 214
GCC COUNTRIES: ARTIFICIAL INTELLIGENCE IN PRECISION MEDICINE MARKET, BY TOOL, 2022–2030 (USD MILLION)
TABLE 215
GCC COUNTRIES: ARTIFICIAL INTELLIGENCE IN PRECISION MEDICINE MARKET, BY DEPLOYMENT, 2022–2030 (USD MILLION)
TABLE 216
GCC COUNTRIES: ARTIFICIAL INTELLIGENCE IN PRECISION MEDICINE MARKET, BY END USER, 2022–2030 (USD MILLION)
TABLE 217
REST OF MIDDLE EAST & AFRICA: ARTIFICIAL INTELLIGENCE IN PRECISION MEDICINE MARKET, BY APPLICATION, 2022–2030 (USD MILLION)
TABLE 218
REST OF MIDDLE EAST & AFRICA: ARTIFICIAL INTELLIGENCE IN PRECISION MEDICINE MARKET, BY THERAPEUTIC AREA, 2022–2030 (USD MILLION)
TABLE 219
REST OF MIDDLE EAST & AFRICA: ARTIFICIAL INTELLIGENCE IN PRECISION MEDICINE MARKET, BY COMPONENT, 2022–2030 (USD MILLION)
TABLE 220
REST OF MIDDLE EAST & AFRICA: ARTIFICIAL INTELLIGENCE IN PRECISION MEDICINE MARKET, BY TOOL, 2022–2030 (USD MILLION)
TABLE 221
REST OF MIDDLE EAST & AFRICA: ARTIFICIAL INTELLIGENCE IN PRECISION MEDICINE MARKET, BY DEPLOYMENT, 2022–2030 (USD MILLION)
TABLE 222
REST OF MIDDLE EAST & AFRICA: ARTIFICIAL INTELLIGENCE IN PRECISION MEDICINE MARKET, BY END USER, 2022–2030 (USD MILLION)
TABLE 223
OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS IN AI PRECISION MEDICINE MARKET, JANUARY 2021–OCTOBER 2024
TABLE 224
ARTIFICIAL INTELLIGENCE IN PRECISION MEDICINE MARKET: DEGREE OF COMPETITION
TABLE 225
ARTIFICIAL INTELLIGENCE IN PRECISION MEDICINE MARKET: THERAPEUTIC AREA FOOTPRINT, 2023
TABLE 226
ARTIFICIAL INTELLIGENCE IN PRECISION MEDICINE MARKET: END USER FOOTPRINT, 2023
TABLE 227
ARTIFICIAL INTELLIGENCE IN PRECISION MEDICINE MARKET: COMPONENT FOOTPRINT, 2023
TABLE 228
ARTIFICIAL INTELLIGENCE IN PRECISION MEDICINE MARKET: DEPLOYMENT FOOTPRINT, 2023
TABLE 229
ARTIFICIAL INTELLIGENCE IN PRECISION MEDICINE MARKET: REGION FOOTPRINT, 2023
TABLE 230
ARTIFICIAL INTELLIGENCE IN PRECISION MEDICINE MARKET: DETAILED LIST OF KEY STARTUP/SME PLAYERS, 2023
TABLE 231
ARTIFICIAL INTELLIGENCE IN PRECISION MEDICINE MARKET: COMPETITIVE BENCHMARKING OF KEY EMERGING PLAYERS/STARTUPS, BY REGION, 2023
TABLE 232
ARTIFICIAL INTELLIGENCE IN PRECISION MEDICINE MARKET: PRODUCT LAUNCHES, JANUARY 2021–OCTOBER 2024
TABLE 233
ARTIFICIAL INTELLIGENCE IN PRECISION MEDICINE MARKET: DEALS, J ANUARY 2021–OCTOBER 2024
TABLE 234
ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET: EXPANSIONS, JANUARY 2021–OCTOBER 2024
TABLE 235
ARTIFICIAL INTELLIGENCE IN PRECISION MEDICINE MARKET: OTHER DEVELOPMENTS, JANUARY 2021–OCTOBER 2024
TABLE 236
NVIDIA CORPORATION: COMPANY OVERVIEW
TABLE 237
NVIDIA CORPORATION: PRODUCTS/SERVICES/SOLUTIONS OFFERED
TABLE 238
NVIDIA CORPORATION: PRODUCT LAUNCHES
TABLE 239
NVIDIA CORPORATION: DEALS
TABLE 240
EXSCIENTIA: COMPANY OVERVIEW
TABLE 241
EXSCIENTIA: PRODUCTS/SERVICES/SOLUTIONS OFFERED
TABLE 242
EXSCIENTIA: PRODUCT LAUNCHES
TABLE 243
EXSCIENTIA: DEALS
TABLE 244
EXSCIENTIA: EXPANSIONS
TABLE 245
EXSCIENTIA: OTHER DEVELOPMENTS
TABLE 246
GOOGLE: COMPANY OVERVIEW
TABLE 247
GOOGLE: PRODUCTS/SERVICES/SOLUTIONS OFFERED
TABLE 248
GOOGLE: PRODUCT LAUNCHES
TABLE 250
GOOGLE: EXPANSIONS
TABLE 251
ILLUMINA, INC.: COMPANY OVERVIEW
TABLE 252
ILLUMINA, INC.: PRODUCTS/SERVICES/SOLUTIONS OFFERED
TABLE 253
ILLUMINA, INC.: PRODUCT LAUNCHES
TABLE 254
ILLUMINA, INC.: DEALS
TABLE 255
TEMPUS: COMPANY OVERVIEW
TABLE 256
TEMPUS: PRODUCTS/SERVICES/SOLUTIONS OFFERED
TABLE 257
TEMPUS: PRODUCT LAUNCHES
TABLE 259
TEMPUS: EXPANSIONS
TABLE 260
TEMPUS: OTHER DEVELOPMENTS
TABLE 261
BENEVOLENTAI: COMPANY OVERVIEW
TABLE 262
BENEVOLENTAI: PRODUCTS/SERVICES/SOLUTIONS OFFERED
TABLE 263
BENEVOLENTAI: DEALS
TABLE 264
MICROSOFT CORPORATION: COMPANY OVERVIEW
TABLE 265
MICROSOFT CORPORATION: PRODUCTS/SERVICES/SOLUTIONS OFFERED
TABLE 266
MICROSOFT CORPORATION: DEALS
TABLE 267
IBM: COMPANY OVERVIEW
TABLE 268
IBM: PRODUCTS/SERVICES/SOLUTIONS OFFERED
TABLE 270
GE HEALTHCARE: COMPANY OVERVIEW
TABLE 271
GE HEALTHCARE: PRODUCTS/SERVICES/SOLUTIONS OFFERED
TABLE 272
GE HEALTHCARE: PRODUCT LAUNCHES
TABLE 273
GE HEALTHCARE: DEALS
TABLE 274
GE HEALTHCARE: OTHER DEVELOPMENTS
TABLE 275
DEEP GENOMICS: COMPANY OVERVIEW
TABLE 276
DEEP GENOMICS: PRODUCTS/SERVICES/SOLUTIONS OFFERED
TABLE 277
DEEP GENOMICS: PRODUCT LAUNCHES
TABLE 278
DEEP GENOMICS: DEALS
TABLE 279
DEEP GENOMICS: OTHER DEVELOPMENTS
TABLE 280
SIEMENS HEALTHINEERS AG: COMPANY OVERVIEW
TABLE 281
SIEMENS HEALTHINEERS AG: PRODUCTS/SOLUTIONS/SERVICES OFFERED
TABLE 282
SIEMENS HEALTHINEERS AG: DEALS
TABLE 283
BIOXCEL THERAPEUTICS, INC.: COMPANY OVERVIEW
TABLE 284
BIOXCEL THERAPEUTICS, INC.: PRODUCTS/SOLUTIONS/SERVICES OFFERED
TABLE 285
BIOXCEL THERAPEUTICS, INC.: DEALS
TABLE 286
BIOXCEL THERAPEUTICS, INC.: OTHER DEVELOPMENTS
TABLE 287
INSILICO MEDICINE: COMPANY OVERVIEW
TABLE 288
INSILICO MEDICINE: PRODUCTS/SERVICES/SOLUTIONS OFFERED
TABLE 289
INSILICO MEDICINE: PRODUCT LAUNCHES
TABLE 290
INSILICO MEDICINE: DEALS
TABLE 291
INSILICO MEDICINE: OTHER DEVELOPMENTS
TABLE 292
PATHAI, INC.: COMPANY OVERVIEW
TABLE 293
PATHAI, INC.: PRODUCTS/SERVICES/SOLUTIONS OFFERED
TABLE 294
PATHAI, INC.: PRODUCT LAUNCHES
TABLE 295
PATHAI, INC.: DEALS
TABLE 296
PATHAI, INC.: OTHER DEVELOPMENTS
TABLE 297
VERGE GENOMICS: COMPANY OVERVIEW
TABLE 298
VERGE GENOMICS: PRODUCTS/SERVICES/SOLUTIONS OFFERED
TABLE 299
VERGE GENOMICS: DEALS
TABLE 300
GUARDANT HEALTH, INC.: COMPANY OVERVIEW
TABLE 301
GUARDANT HEALTH, INC.: PRODUCTS/SERVICES/SOLUTIONS OFFERED
TABLE 302
GUARDANT HEALTH, INC.: PRODUCT LAUNCHES
TABLE 303
GUARDANT HEALTH, INC.: DEALS
TABLE 304
GUARDANT HEALTH, INC.: OTHER DEVELOPMENTS
TABLE 305
GRAIL, INC.: COMPANY OVERVIEW
TABLE 306
GRAIL, INC.: PRODUCTS/SERVICES/SOLUTIONS OFFERED
TABLE 307
GRAIL, INC.: DEALS
TABLE 308
FOUNDATION MEDICINE, INC.: COMPANY OVERVIEW
TABLE 309
FOUNDATION MEDICINE, INC.: PRODUCTS/SERVICES/SOLUTIONS OFFERED
TABLE 310
FOUNDATION MEDICINE, INC.: DEALS
TABLE 311
FOUNDATION MEDICINE, INC.: OTHER DEVELOPMENTS
TABLE 312
PROSCIA INC.: COMPANY OVERVIEW
TABLE 313
PROSCIA INC.: PRODUCTS/SERVICES/SOLUTIONS OFFERED
TABLE 314
PROSCIA INC.: PRODUCT LAUNCHES
TABLE 315
PROSCIA INC.: DEALS
TABLE 316
PROSCIA INC.: OTHER DEVELOPMENTS
TABLE 317
FLATIRON HEALTH: COMPANY OVERVIEW
TABLE 318
FLATIRON HEALTH: PRODUCTS/SERVICES/SOLUTIONS OFFERED
TABLE 319
FLATIRON HEALTH: DEALS
TABLE 320
FLATIRON HEALTH: OTHER DEVELOPMENTS
TABLE 321
PREDICTIVE ONCOLOGY: COMPANY OVERVIEW
TABLE 322
PAIGE AI, INC.: COMPANY OVERVIEW
TABLE 323
DENSITAS INC.: COMPANY OVERVIEW
TABLE 324
ZEPHYR AI, INC.: COMPANY OVERVIEW
TABLE 325
NUCLEAI, INC.: COMPANY OVERVIEW
FIGURE 1
AI IN PRECISION MEDICINE MARKET SEGMENTATION & REGIONAL SCOPE
FIGURE 2
STUDY YEARS CONSIDERED
FIGURE 5
INSIGHTS FROM PRIMARY EXPERTS
FIGURE 6
BREAKDOWN OF PRIMARY INTERVIEWS (DEMAND SIDE), BY COMPANY TYPE, DESIGNATION, AND REGION
FIGURE 7
MARKET SIZE ESTIMATION: REVENUE SHARE ANALYSIS
FIGURE 8
TOP-DOWN APPROACH
FIGURE 9
CAGR PROJECTIONS, BY MARKET DYNAMIC, 2024–2030
FIGURE 10
CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS
FIGURE 11
DATA TRIANGULATION
FIGURE 12
ARTIFICIAL INTELLIGENCE IN PRECISION MEDICINE MARKET, BY APPLICATION, 2024 VS. 2030 (USD MILLION)
FIGURE 13
ARTIFICIAL INTELLIGENCE IN PRECISION MEDICINE MARKET, BY THERAPEUTIC AREA, 2024 VS. 2030 (USD MILLION)
FIGURE 14
ARTIFICIAL INTELLIGENCE IN PRECISION MEDICINE MARKET, BY COMPONENT, 2024 VS. 2030 (USD MILLION)
FIGURE 15
ARTIFICIAL INTELLIGENCE IN PRECISION MEDICINE MARKET, BY TOOL, 2024 VS. 2030 (USD MILLION)
FIGURE 16
ARTIFICIAL INTELLIGENCE IN PRECISION MEDICINE MARKET, BY DEPLOYMENT, 2024 VS. 2030 (USD MILLION)
FIGURE 17
ARTIFICIAL INTELLIGENCE IN PRECISION MEDICINE MARKET, BY END USER, 2024 VS. 2030 (USD MILLION)
FIGURE 18
ARTIFICIAL INTELLIGENCE IN PRECISION MEDICINE MARKET: GEOGRAPHICAL SNAPSHOT
FIGURE 19
GROWING FOCUS ON COST-EFFECTIVE PROCESSES AND FAVORABLE GOVERNMENT SUPPORT AND FUNDING TO DRIVE MARKET
FIGURE 20
NORTH AMERICA TO DOMINATE AI IN PRECISION MEDICINE MARKET DURING FORECAST PERIOD
FIGURE 21
PHARMACEUTICAL COMPANIES IN NORTH AMERICA ACCOUNTED FOR LARGEST MARKET SHARE IN 2023
FIGURE 22
INDIA TO REGISTER HIGHEST GROWTH RATE DURING FORECAST PERIOD
FIGURE 23
EMERGING MARKETS TO REGISTER HIGHER GROWTH RATES DURING FORECAST PERIOD
FIGURE 24
ARTIFICIAL INTELLIGENCE IN PRECISION MEDICINE MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
FIGURE 25
APPROVAL RATE OF PERSONALIZED MEDICINES BY US FDA, 2015–2023
FIGURE 26
HEALTH SECURITY BREACHES, 2009–2023
FIGURE 27
INDIVIDUALS AFFECTED BY HEALTHCARE SECURITY BREACHES, 2009–2023 (MILLION)
FIGURE 28
USE CASES FOR PREDICTIVE ANALYTICS IN HEALTHCARE
FIGURE 29
REVENUE SHIFT IN AI IN PRECISION MEDICINE MARKET
FIGURE 30
AI IN PRECISION MEDICINE MARKET: ECOSYSTEM ANALYSIS
FIGURE 31
AI IN PRECISION MEDICINE MARKET: VALUE CHAIN ANALYSIS, 2023
FIGURE 32
AI IN PRECISION MEDICINE MARKET: PORTER’S FIVE FORCES ANALYSIS
FIGURE 33
JURISDICTION ANALYSIS: TOP PATENT APPLICANT COUNTRIES, JANUARY 2015–NOVEMBER 2024
FIGURE 34
KEY PATENTS IN AI IN PRECISION MEDICINE MARKET, JANUARY 2015– NOVEMBER 2024
FIGURE 35
INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR TOP THREE END USERS
FIGURE 36
KEY BUYING CRITERIA FOR END USERS
FIGURE 38
MARKET POTENTIAL OF AI/GENERATIVE AI IN ENHANCING AI IN PRECISION MEDICINE ACROSS INDUSTRIES
FIGURE 39
IMPACT OF AI/GEN AI ON INTERCONNECTED AND ADJACENT ECOSYSTEMS
FIGURE 40
NORTH AMERICA: ARTIFICIAL INTELLIGENCE IN PRECISION MEDICINE MARKET SNAPSHOT
FIGURE 41
ASIA PACIFIC: ARTIFICIAL INTELLIGENCE IN PRECISION MEDICINE MARKET SNAPSHOT
FIGURE 42
REVENUE ANALYSIS OF KEY PLAYERS, 2019–2023 (USD MILLION)
FIGURE 43
MARKET SHARE ANALYSIS OF KEY PLAYERS, 2023
FIGURE 44
ARTIFICIAL INTELLIGENCE IN PRECISION MEDICINE MARKET: RANKING OF KEY PLAYERS, 2023
FIGURE 45
ARTIFICIAL INTELLIGENCE IN PRECISION MEDICINE MARKET: COMPANY EVALUATION MATRIX (KEY PLAYERS), 2023
FIGURE 46
ARTIFICIAL INTELLIGENCE IN PRECISION MEDICINE MARKET: COMPANY FOOTPRINT, 2023
FIGURE 47
ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET: COMPANY EVALUATION MATRIX (STARTUPS/SMES), 2023
FIGURE 48
YEAR-TO-DATE (YTD) PRICE TOTAL RETURN AND 5-YEAR STOCK BETA OF KEY VENDORS, 2024
FIGURE 49
EV/EBITDA OF KEY VENDORS, 2024
FIGURE 50
ARTIFICIAL INTELLIGENCE IN PRECISION MEDICINE MARKET: BRAND/PRODUCT COMPARATIVE ANALYSIS
FIGURE 51
NVIDIA CORPORATION: COMPANY SNAPSHOT
FIGURE 52
EXSCIENTIA: COMPANY SNAPSHOT
FIGURE 53
GOOGLE: COMPANY SNAPSHOT
FIGURE 54
ILLUMINA, INC.: COMPANY SNAPSHOT
FIGURE 55
BENEVOLENTAI: COMPANY SNAPSHOT
FIGURE 56
MICROSOFT CORPORATION: COMPANY SNAPSHOT
FIGURE 57
IBM: COMPANY SNAPSHOT
FIGURE 58
GE HEALTHCARE: COMPANY SNAPSHOT
FIGURE 59
SIEMENS HEALTHINEERS AG: COMPANY SNAPSHOT
FIGURE 60
GUARDANT HEALTH: COMPANY SNAPSHOT
Growth opportunities and latent adjacency in AI in Precision Medicine Market